Ontario launched its vaccination campaign this week, allowing most people to get COVID-19 and flu vaccines.
According to the latest update from Ottawa Public Health (OPH), Ottawa health facilities are at high risk for respiratory diseases such as COVID, influenza and respiratory syncytial virus (RSV).
Comments closedThe province cranked the 2023-24 respiratory season vaccine campaign wide open this week, allowing most people to get updated COVID-19 and flu vaccines.
Ottawa’s health-care institutions are at high risk from respiratory illness such as COVID, flu and respiratory syncytial virus (RSV), according to Ottawa Public Health (OPH)’s latest update.
Comments closedThe COVID-19 vaccination campaign in 141 countries averted 2.4 million excess deaths by August 2021 and would have saved another 670,000 more lives had vaccines been distributed equitably, estimates a working paper from University of Southern California (USC) and Brown University researchers.
Comments closedProvince says high demand for COVID-19 shots limiting availability in some locations.
Comments closedWaterloo pharmacist Erin McClure says her phone has been ringing off the hook lately with people hoping to make appointments for their flu and COVID-19 shots.
Comments closedOntario residents who are six months and older will be able to receive their free flu shot and the new COVID‑19 vaccine starting on Monday.
Comments closedStarting today, the general public can book an appointment to get a fall booster shot for COVID-19 and influenza (flu) through Toronto Public Health (TPH) ahead of a potentially challenging season for respiratory illness.
Comments closedAs the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.
Comments closedEuropean Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.
The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.
Comments closedThe US Department of Health and Human Services (HHS) today announced more than $500 million more in funding through its Project NextGen program to speed the development of new vaccines and treatments for COVID-19.
Comments closedIreland’s Covid-19 vaccination programme prevented 16,000 deaths and hugely reduced hospital and intensive care admissions, according to a Health Service Executive study.
Comments closedWhen COVID-19 put vaccine safety into the spotlight, Lydia Greene re-examined her past beliefs — and now hopes she can help others do the same.
Comments closedAppointments are now available in Nova Scotia for a new monovalent Moderna COVID-19 vaccine, which the provincial government says provides the best protection against the latest strain of the virus.
Comments closedThe last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.
Comments closedThe last manufacturer to offer an alternative to COVID-19 mRNA vaccines in Canada hopes to meet the government’s 2024 deadline for domestic dose production.
Novavax, based in Maryland, USA, held a press conference on Wednesday to tout the safety and efficacy of its new vaccine, which targets newer strains of COVID-19.
Comments closedNew Brunswick has no plans to change its advice about COVID-19, including returning to mandatory masking, the Department of Health said Wednesday.
Comments closedThe Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.
Comments closed